Lisinopril vs Trastuzumab
Lisinopril vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Lisinopril and Trastuzumab.
Mechanism of Action
Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Lisinopril — 12 hours; Trastuzumab — 28 days.
Chemical Properties
Molecular Formula: Lisinopril — C21H31N3O5.
Molecular Weight: Lisinopril — 405.4900 g/mol.
Type: Lisinopril — Small molecule; Trastuzumab — Antibody.